$ANIK News

Anika to Issue Third Quarter 2026 Financial Results on Friday, November 6, 2026

B. Riley Securities Assumes Anika Therapeutics at Buy, Raises Price Target to $23

Novartis' Del-desiran Fails Late-Stage DM1 Study, Shares Fall

Anika (ANIK) Is a Great Choice for 'Trend' Investors, Here's Why

Anika Therapeutics (ANIK) Is Up 11.10% in One Week: What You Should Know

Anika (ANIK) Q2 2026 Earnings Call Transcript

Anika (ANIK) is on the Move, Here's Why the Trend Could be Sustainable

Anika Therapeutics (ANIK) Stock Fair Value Rises After Q2 Beat And Higher Guidance

These 2 Biotech Stocks Hit New 52-Week Highs Today – And CORT Clocked Its Best Day In Nearly 16 Months

Clarevia Ventures Welcomes Cheryl R. Blanchard, Ph.D., as Executive in Residence

B. Riley Securities Maintains Buy on Anika Therapeutics, Raises Price Target to $21

Anika Therapeutics Inc (ANIK) Q2 2026 Earnings Call Highlights: Record Revenue and Margin ...

Anika Therapeutics, Inc. (ANIK) Q2 2026 Earnings Call Transcript

Anika Therapeutics Q2 Earnings Call Highlights

Anika Therapeutics (NASDAQ:ANIK) Soars on Q2 Earnings Beat, Revenue and EPS Top Estimates

Anika Reports Second Quarter 2026 Financial Results

Anika Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation

Anika Therapeutics Raises FY2026 Sales Guidance from $114.000M-$122.500M to $118.460M-$124.101M vs $118.612M Est

Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)